Corbevax for 12-18 years. It is the second vaccine for children after Bharat Biotech's Covaxin. However, the government has not yet decided on vaccination for less than 15 years.
The Drugs Controller General of India (DCGI)'s approval comes after the Subject Expert Committee on COVID-19 of the CDSCO on February 14 recommended granting restricted EUA to Corbevax for the 12 to 18 years age group after deliberating on Biological E's application. Corbevax vaccine for children: All you need to know 1.
The vaccine is India's first indigenously developed Receptor Binding Domain (RBD) Protein sub-unit vaccine against Covid-19.
2. Cobrevax is a “recombinant protein sub-unit" vaccine, developed from a component of the spike protein on the virus’s surface, which helps the body build the immune response against the virus.